Ulf Lützen

German Multicenter Study Investigating¹⁷⁷Lu-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients

Kambiz Rahbar, Hojjat Ahmadzadehfar, Clemens Kratochwil et al. · Journal of Nuclear Medicine · 2016 · 832 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Cutting Edge: Immunological Consequences and Trafficking of Human Regulatory Macrophages Administered to Renal Transplant Recipients

James A. Hutchinson, Paloma Riquelme, Birgit Sawitzki et al. · The Journal of Immunology · 2011 · 236 citations · Full text

Life Sciences, Immunology, Nephrology +17

Man as living bioreactor: Fate of an exogenously prepared customized tissue-engineered mandible

Patrick H. Warnke, Ingo N. Springer, Yahya Açil et al. · Biomaterials · 2006 · 235 citations

Engineering, Bioengineering, Biotechnology +10

Vedolizumab is associated with changes in innate rather than adaptive immunity in patients with inflammatory bowel disease

Elisa Rosati, C. Marie Dowds, Konrad Aden et al. · Gut · 2018 · 208 citations

Life Sciences, Immunology, Pharmacotherapy +17

Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-Plan): a multicentre, open-label, randomised, controlled trial

Ursula Nestle, Tanja Schimek‐Jasch, Stephanie Kremp et al. · The Lancet Oncology · 2020 · 177 citations

Medicine, Oncology, Radiation Oncology +14